Paloma Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,156
| Closed | -$913K | – | 139 |
|
|
2025
Q1 | $913K | Buy |
+10,156
| New | +$909K | 0.11% | 86 |
|
|
2024
Q3 | – | Sell |
-15,610
| Closed | -$1.23M | – | 1476 |
|
|
2024
Q2 | $1.23M | Buy |
+15,610
| New | +$1.28M | 0.03% | 466 |
|
|
2022
Q3 | – | Sell |
-4,900
| Closed | -$440K | – | 1213 |
|
|
2022
Q2 | $440K | Sell |
4,900
-300
| -6% | -$30.4K | 0.02% | 647 |
|
|
2022
Q1 | $577K | Sell |
5,200
-172,344
| -97% | -$18.2M | 0.02% | 668 |
|
|
2021
Q4 | $18.4M | Buy |
177,544
+141,203
| +389% | +$16.4M | 0.27% | 35 |
|
|
2021
Q3 | $4.55M | Buy |
36,341
+18,856
| +108% | +$2.44M | 0.11% | 111 |
|
|
2021
Q2 | $2.17M | Buy |
17,485
+7,808
| +81% | +$980K | 0.04% | 402 |
|
|
2021
Q1 | $1.14M | Buy |
+9,677
| New | +$1.13M | 0.02% | 631 |
|
|
2020
Q4 | – | Sell |
-46,666
| Closed | -$4.85M | – | 1998 |
|
|
2020
Q3 | $4.85M | Sell |
46,666
-95,530
| -67% | -$9.59M | 0.12% | 146 |
|
|
2020
Q2 | $13M | Buy |
142,196
+25,228
| +22% | +$2.42M | 0.23% | 70 |
|
|
2020
Q1 | $10.5M | Buy |
116,968
+84,366
| +259% | +$8.98M | 0.59% | 22 |
|
|
2019
Q4 | $3.7M | Buy |
32,602
+14,102
| +76% | +$1.55M | 0.06% | 348 |
|
|
2019
Q3 | $2.01M | Sell |
18,500
-23,033
| -55% | -$2.4M | 0.04% | 428 |
|
|
2019
Q2 | $4.04M | Sell |
41,533
-32,103
| -44% | -$2.93M | 0.07% | 228 |
|
|
2019
Q1 | $6.71M | Buy |
73,636
+61,613
| +512% | +$5.51M | 0.16% | 105 |
|
|
2018
Q4 | $1.09M | Buy |
+12,023
| New | +$1.12M | 0.03% | 427 |
|
|
2018
Q3 | – | Sell |
-39,800
| Closed | -$3.68M | – | 484 |
|
|
2018
Q2 | $3.41M | Buy |
39,800
+17,583
| +79% | +$1.47M | 0.06% | 270 |
|
|
2018
Q1 | $1.78M | Buy |
22,217
+8,492
| +62% | +$700K | 0.03% | 651 |
|
|
2017
Q4 | $1.11M | Sell |
13,725
-148,198
| -92% | -$11.9M | 0.01% | 989 |
|
|
2017
Q3 | $12.6M | Sell |
161,923
-8,478
| -5% | -$704K | 0.17% | 84 |
|
|
2017
Q2 | $15.1M | Buy |
170,401
+107,074
| +169% | +$9.03M | 0.18% | 72 |
|
|
2017
Q1 | $5.1M | Sell |
63,327
-1,639
| -3% | -$128K | 0.06% | 294 |
|
|
2016
Q4 | $4.63M | Buy |
+64,966
| New | +$5.1M | 0.05% | 279 |
|
|
2015
Q1 | – | Sell |
-10,239
| Closed | -$740K | – | 1327 |
|
|
2014
Q4 | $740K | Sell |
10,239
-93,745
| -90% | -$6.51M | 0.03% | 524 |
|
|
2014
Q3 | $6.44M | Buy |
+103,984
| New | +$6.61M | 0.3% | 74 |
|
|
2013
Q4 | – | Sell |
-50,000
| Closed | -$2.66M | – | 1109 |
|
|
2013
Q3 | $2.66M | Buy |
+50,000
| New | +$2.69M | 0.11% | 163 |
|
Other funds holding MDT
Paloma Partners's MDT Position: Q2 2025 in Review
Paloma Partners sold out of Medtronic (MDT) in Q2 2025, closing a stake of 10,156 shares — an estimated $913K sold.
Paloma Partners first reported a position in MDT in Q3 2013 and held it in 26 quarters. The position peaked at $18.4M in Q4 2021. 2,145 funds tracked by Wall St. Rank hold MDT as of Q2 2025.
- Paloma Partners reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
- Paloma Partners sold 10,156 Medtronic shares in Q2 2025, an estimated $913K.
- Paloma Partners first reported a position in Medtronic in Q3 2013 and held it in 26 quarters.
- Paloma Partners's Medtronic position peaked at $18.4M in Q4 2021.
- 2,145 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.
Based on Paloma Partners's 13F filing for Q2 2025, filed 14 Aug 2025.